Aduro closes US$15.6M offering, files LIFE amendment
Aduro Clean Technologies Inc closed its underwritten public offering, raising US$15,635,404 through the sale of 1,028,645 common shares at US$15.20 per share. Concurrently, the company filed an amended and restated offering document for its non-brokered private placement, the LIFE Offering, targeting up to US$7,169,810. The LIFE Offering is expected to close on or about June 19, 2026, subject to TSX approval.

*this image is generated using AI for illustrative purposes only.
Aduro Clean Technologies Inc has closed its underwritten U.S. and Canadian public offering, raising gross proceeds of US$15,635,404, and filed an amended and restated offering document for its concurrent private placement. The capital from the public offering will fund the design, engineering, and construction of a first-of-a-kind demonstration-scale industrial plant (FOAK Plant), alongside ongoing research and development costs and general corporate purposes. Following the completion of the public offering, the company filed the Amended and Restated LIFE Offering Document in accordance with applicable securities laws.
The public offering consisted of 1,028,645 common shares priced at US$15.20 per share. Canaccord Genuity acted as the sole bookrunning manager and representative of the several underwriters for the transaction. The offering was made pursuant to an effective shelf registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission. The related base shelf prospectus and prospectus supplement were filed with securities regulatory authorities in British Columbia and Ontario.
The company had previously announced a concurrent non-brokered private placement termed the LIFE Offering, targeting gross proceeds of up to US$7,169,810. The LIFE Offering consists of up to 471,698 common shares at a price of US$15.20 (C$21.20) per Offered Share. The closing of the public offering was not conditional on the closing of the LIFE Offering. The LIFE Offering is expected to close on or about June 19, 2026, subject to applicable securities and the policies of the Toronto Stock Exchange (TSX).
Public Offering Details
| Component | Shares | Price Per Share | Gross Proceeds |
|---|---|---|---|
| Public Offering | 1,028,645 | US$15.20 | US$15,635,404 |
| LIFE Offering | 471,698 | US$15.20 | US$7,169,810 |
The TSX has conditionally approved the LIFE Offering, with final approval subject to the completion of customary conditions. The company is relying on the exemption set forth in Section 602.1 of the TSX Company Manual in connection with the LIFE Offering. Directors and/or officers may participate in the LIFE Offering, which would constitute a "related party transaction" under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions. The company expects to rely on exemptions from formal valuation and minority shareholder approval requirements as the transaction value is not expected to exceed 25% of the company's market capitalization.
All foreign exchange calculations referenced in the announcements are based on the exchange rate posted by the Bank of Canada on June 9, 2026, of US$1 = C$1.3947. The Amended and Restated LIFE Offering Document is available under the company's profile on SEDAR+ at www.sedarplus.ca and on the company's website at www.adurocleantech.com .
What is the projected timeline for the design, engineering, and construction of the FOAK Plant?
How will the successful operation of the demonstration-scale plant influence potential partnerships or commercial licensing agreements?
What specific R&D initiatives will receive funding from the proceeds, and how do they align with the company's long-term strategy?






















